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Deregulation of microRNAs (miRNAs) plays an impor-
tant role in human carcinogenesis. However, miRNA
deregulation in the pre-malignant lesions and expression
changes during multistep hepatocarcinogenesis remain
elusive. We investigated the expression changes of seven
cancer-related miRNAs during the early stages of HBV-
related hepatocarcinogenesis, including dysplastic
nodules (DN), small hepatocellular carcinomas (HCCs),
and their corresponding non-tumorous livers. We found
that down-regulation of miR-145 and miR-199b and up-
regulation of miR-224 were frequently observed in pre-
malignant DNs and these changes persisted throughout
HCC development. Restoration of miR-145 in both
HepG2 and Hep3B HCC cells significantly inhibited cell
proliferation and reduced cell migration and cell inva-
sion. Furthermore, these inhibitory functions of miR-145
could be substantially reduced by anti-miR-145 inhibitor.
Our results showed that miRNA deregulation was an
early event and accumulated throughout the various
steps of HBV-associated hepatocarcinogenesis.
On the other hand, we investigated the mechanisms of
HCC metastasis and identified an antimetastatic miRNA,
miR-139, that is down-regulated in human HCC samples.
Down-regulation of miR-139 in HCC was associated with
poor prognosis of patients and features of metastatic
tumors, including venous invasion, microsatellite forma-
tion, absence of tumor encapsulation, and reduced differ-
entiation. miR-139 expression was reduced in metastatic
HCC tumors as compared with primary tumors. Overex-
pression of miR-139 in HCC cells significantly reduced
cell migration and invasion in vitro and the incidence and
severity of lung metastasis from orthotopic liver tumors in
mice. miR-139 interacted with the 3’ untranslated region
of Rho-kinase 2 (ROCK2) and reduced its expression in
HCC cells. Levels of miR-139 correlated inversely with
ROCK2 protein in human HCC samples. Expanding
insight into the keys of miRNA dysregulation involved in
HCC metastasis will yield important clues to our under-
standing of the complicated mechanisms underlying HCC
progression and may enhance the development of new
therapeutic regimens in treating advanced HCCs.
Presence of tumor thrombi in the portal veins (venous
metastases) is a clinicopathological feature of metastatic
HCCs. By analyzing the miRNA expression profiles of
non-tumorous livers, primary HCCs, and venous metas-
tases in the same livers from 20 HCC patients with low
density microarray (LDA), we identified the precise altera-
tions of miRNA expression from non-tumorous livers to
primary HCCs and venous metastases globally. Non-
tumorous livers were distinctly segregated from primary
HCCs and venous metastases, whereas no discernible dif-
ference in the expression pattern could be found between
primary HCCs and venous metastases. However, a marked
global reduction of miRNA expression levels was detected
in venous metastases, as compared with primary HCCs.
These data suggest that miRNA deregulation may be an
early event in liver carcinogenesis and the later global
miRNA down-regulation aggravates the pre-existing
miRNA deregulation to further promote HCC metastasis.
Our study has enriched the current understanding of the
deregulation of miRNAs in HCC progression and high-
lighted the sequential and distinctive alterations of miRNA
expression in primary HCC and venous metastasis
formation.
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